MyCEI Login


X-Express: Buprenorphine Prescribing for Beginners


Published Date: 02/23/2022

Expiration Date: 11/18/2024

CE Credit: CME:1CNE: 1CPE: 1


Since this training was published, the federal requirement for practitioners to have a waiver (commonly referred to as the X-Waiver) to prescribe buprenorphine was removed. Additionally, practitioners no longer need to file a notice of intent (NOI) and the limit on the number of patients a practitioner can treat with buprenorphine has been removed. Learn more about these federal changes here.

This one-hour course will teach providers the basics of how to prescribe buprenorphine to treat opioid use disorder. It will discuss the new federal buprenorphine practice guidelines and explain how providers can submit a Notification of Intent to obtain an X-waiver to prescribe buprenorphine. This course will be tailored for primary care and rural health providers.

We also offer case studies, not CE accredited:


Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.


Judith Griffin,MD

Judy Griffin, MD is board-certified in internal medicine and works as a primary care physician and buprenorphine provider at REACH in Ithaca, NY. She serves as the Director of Research at REACH Medical and is the Director of the Rural Health Equity Training Collaborative (RHETC). Dr. Griffin also holds an appointment as a Clinical Instructor in Medicine at Weill Cornell Medical College and is a member of the Criminal Justice-Alternatives to Incarceration Advisory Board for Tompkins County.

Learning Objectives

  • Describe the goals and principles of buprenorphine treatment for opioid use disorder.
  • Explain the new training requirements in order to prescribe buprenorphine.
  • Discuss the pharmacology of buprenorphine as compared with other medications for opioid use disorder.
  • Review best practices for initiation, dose stabilization, maintenance and discontinuation.
  • Discuss clinical cases that demonstrate how buprenorphine treatment can be delivered in various clinical settings.

Continuing Education Credit Information